COX-2 as a determinant of lower disease-free survival for patients affected by ameloblastoma (2018)
- Authors:
- Montezuma, Marco Aurélio Petron
- Fonseca, Felipe Paiva - Universidade Federal de Minas Gerais (UFMG)
- Benitesa, Bernar Monteiro
- Soares, Ciro Dantas - Universidade Estadual de Campinas (UNICAMP)
- Silva, Gleyson Kleber do Amaral - Universidade Estadual de Campinas (UNICAMP)
- Almeida, Oslei Paes de - Universidade Estadual de Campinas (UNICAMP)
- Soares, Fernando Augusto
- Pagano, Rosana Lima
- Fregnani, Eduardo Rodrigues
- Autor USP: SOARES, FERNANDO AUGUSTO - FO
- Unidade: FO
- DOI: 10.1016/j.prp.2018.03.014
- Subjects: AMELOBLASTOMA; TUMORES ODONTOGÊNICOS
- Language: Inglês
- Imprenta:
- Publisher place: Elsevier GmbH - Urban und Fischer
- Date published: 2018
- Source:
- Título: Pathology, Research and Practice
- ISSN: 1618-0631
- Volume/Número/Paginação/Ano: v. 214, p. 907-913, June 2018
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MONTEZUMA, Marco Aurélio Petron et al. COX-2 as a determinant of lower disease-free survival for patients affected by ameloblastoma. Pathology, Research and Practice, v. 214, p. 907-913, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.prp.2018.03.014. Acesso em: 14 fev. 2026. -
APA
Montezuma, M. A. P., Fonseca, F. P., Benitesa, B. M., Soares, C. D., Silva, G. K. do A., Almeida, O. P. de, et al. (2018). COX-2 as a determinant of lower disease-free survival for patients affected by ameloblastoma. Pathology, Research and Practice, 214, 907-913. doi:10.1016/j.prp.2018.03.014 -
NLM
Montezuma MAP, Fonseca FP, Benitesa BM, Soares CD, Silva GK do A, Almeida OP de, Soares FA, Pagano RL, Fregnani ER. COX-2 as a determinant of lower disease-free survival for patients affected by ameloblastoma [Internet]. Pathology, Research and Practice. 2018 ; 214 907-913.[citado 2026 fev. 14 ] Available from: https://doi.org/10.1016/j.prp.2018.03.014 -
Vancouver
Montezuma MAP, Fonseca FP, Benitesa BM, Soares CD, Silva GK do A, Almeida OP de, Soares FA, Pagano RL, Fregnani ER. COX-2 as a determinant of lower disease-free survival for patients affected by ameloblastoma [Internet]. Pathology, Research and Practice. 2018 ; 214 907-913.[citado 2026 fev. 14 ] Available from: https://doi.org/10.1016/j.prp.2018.03.014 - Elevated VEGFA mRNA levels in oral squamous cell carcinomas and tumor margins: a preliminary study
- A comparative study of AJCC and the modified staging system in pT2/pT3 penile squamous cell carcinoma – a validation on an external data set
- Single nucleotide variants in immuneresponse genes and the tumor microenvironment composition predict progression of mantle cell lymphoma
- A call to action: molecular pathology in Brazil
- Digital Pathology in Latin America
- Inhibition of the AnxA1/FPR1 autocrine axis reduces MDA-MB-231 breast cancer cell growth and aggressiveness in vitro and in vivo
- Biopsia de linfonodos em paciente com sida . Experiencia do servico de patologia do hcfmrp / usp, no periodo de 1988 a 1993
- Role of GATA3 as a potential adjunct marker in the differential diagnosis of Paget’s disease of the nipple
- Synchronous ameloblastoma and orthokeratinized odontogenic cyst of the mandible
- The immune landscape of the microenvironment of thyroid cancer is closely related to differentiation status
Informações sobre o DOI: 10.1016/j.prp.2018.03.014 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
